| POS0709 THE RISK OF SERIOUS INFECTIONS IN PATIENTS WITH EARLY INFLAMMATORY ARTHRITIS: RESULTS FROM A LARGE UK COHORT (NEIAA) MA Adas, K Bechman, B Zuckerman, M Russell, S Patel, D Nagra, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 607-608, 2024 | | 2024 |
| OP0076 LONG-TERM OUTCOMES OF REPEAT CYCLES OF RITUXIMAB FOR SYSTEMIC MANIFESTATIONS OF SJOGREN’S DISEASE: MULTICENTRE UK COHORT STUDY MYMD Yusof, J Berry, I Turtsevich, S Pepple, J Arnold, EM Vital, M Gupta, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 128-129, 2024 | | 2024 |
| The management of Sjögren's syndrome: British Society for Rheumatology guideline E Price, S Benjamin, M Bombardieri, S Bowman, S Carty, C Ciurtin, ... Rheumatology, 2024 | | 2024 |
| British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease EJ Price, S Benjamin, M Bombardieri, S Bowman, S Carty, C Ciurtin, ... Rheumatology, keae152, 2024 | | 2024 |
| OA06 Regional differences in work productivity in patients with early rheumatoid arthritis in England and Wales E Alveyn, M Adas, I Sahbudin, A Boonen, K Bechman, MD Russell, ... Rheumatology 63 (Supplement_1), keae163. 006, 2024 | | 2024 |
| OA20 Serious infections hospital admissions and mortality in patients with early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit M Adas, K Bechman, M Russell, I Karafotias, D Nagra, S Patel, ... Rheumatology 63 (Supplement_1), keae163. 020, 2024 | | 2024 |
| P062 Trust performance in managing inflammatory arthritis over time in England and Wales: a latent class analysis approach Z Yang, N Arumalla, MD Russell, K Bechman, E Alveyn, S Gallagher, ... Rheumatology 63 (Supplement_1), keae163. 103, 2024 | | 2024 |
| Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open … A Abhishek, N Peckham, C Pade, JM Gibbons, L Cureton, A Francis, ... The Lancet Rheumatology 6 (2), e92-e104, 2024 | 3 | 2024 |
| News. Coming soon: Updated Sjögren’s Guidelines E Price, C Ciurtin British Society for Rheumatology, 2024 | | 2024 |
| Trust performance in managing inflammatory arthritis over time in England and Wales: a latent class analysis approach Z Yang, N Arumalla, E Alveyn, S Gallagher, E Price, MD Russell, ... Rheumatology Advances in Practice 8 (2), rkae053, 2024 | | 2024 |
| A Viewpoint on Therapeutic Approaches and Unmet Needs in the Management of Young People with Sjӧgren Disease C Ciurtin, E Price Journal Publication Date, 2024 | | 2024 |
| A viewpoint on therapeutic approaches and unmet needs in the management of young people with juvenile Sjӧgren’s Syndrome C Ciurtin, E Price touchREVIEWS in Respiratory & Pulmonary Diseases, 2023 | | 2023 |
| Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren’s syndrome: a randomized, phase 2, double-blind, placebo-controlled study E Price, M Bombardieri, A Kivitz, F Matzkies, O Gurtovaya, A Pechonkina, ... Rheumatology 61 (12), 4797-4808, 2022 | 27 | 2022 |
| Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study … A Abhishek, RJ Boyton, N Peckham, Á McKnight, LC Coates, J Bluett, ... The Lancet Respiratory Medicine 10 (9), 840-850, 2022 | 68 | 2022 |
| Biologics in sjogren’s syndrome E Price Handbook of Biologics for Rheumatological Disorders, 75-84, 2022 | 1 | 2022 |
| Treatment strategies for Sjögren’s syndrome with childhood onset: a systematic review of the literature G Doolan, NM Faizal, C Foley, M Al-Obaidi, EC Jury, E Price, ... Rheumatology 61 (3), 892-912, 2022 | 18 | 2022 |
| Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a … R Lazarus, S Baos, H Cappel-Porter, A Carson-Stevens, M Clout, ... The Lancet 398 (10318), 2277-2287, 2021 | 139 | 2021 |
| Mainstreaming climate change education in UK higher education institutions H Thew, C Graves, D Reay, S Smith, K Petersen, E Bomberg, S Boxley, ... | 5 | 2021 |
| An objective method of diagnosing hydroxychloroquine maculopathy H Hasan, A Lotery, EJ Price, GT Smith Eye 35 (7), 1922-1929, 2021 | 6 | 2021 |
| How to treat Sjögren’s syndrome EJ Price, AN Baer Rheumatology 60 (6), 2574-2587, 2021 | 21 | 2021 |
